Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
delSECUR was a biometric technology company specializing in secure identity authentication through its proprietary del-ID system. The technology utilized electronic scanning of finger characteristics to generate a 'del-gram,' a unique electronic signature derived from biological data that ensured privacy by not storing actual fingerprint images. Although its primary focus was security, delSECUR's technology had significant applications in the healthcare sector, particularly in patient identification and the secure management of electronic medical records. The company was publicly traded on the Pink Sheets under the symbol DLSC before selling its intellectual property to QTech Systems Inc. in 2009 and subsequently dissolving in 2011.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on delSECUR.